Please assess the completion status of the following clinical trial:

Trial Title: Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous Dialysis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who are receiving continuous renal replacement therapy and are prescribed voriconazole therapy for the treatment or prophylaxis of a fungal infection.~Exclusion Criteria:~* Patients expected to be on CRRT for \< 5 days,~* Patients with Child-Pugh C cirrhosis, and~* Patients who are pregnant.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Voriconazole (Type: None): Pharmacokinetic Monitoring

Based on this trial design, predict the completion outcome and termination type (if applicable).